Loading…
Summit Therapeutics Inc. is projected to rise to $23.90 by 2027, a +38% move from its current price of $17.36. SMMT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $16.50 | $17.37 | $18.28 | +0.03% |
| May 30 | $16.16 | $17.37 | $18.68 | +0.06% |
| May 31 | $15.90 | $17.38 | $18.99 | +0.09% |
| Jun 1 | $15.69 | $17.38 | $19.26 | +0.12% |
| Jun 2 | $15.50 | $17.39 | $19.50 | +0.15% |
| Jun 3 | $15.34 | $17.39 | $19.72 | +0.18% |
| Jun 4 | $15.19 | $17.40 | $19.92 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.19 | $17.40 | $19.92 | +0.21% |
| Week 2 | $14.39 | $17.43 | $21.12 | +0.42% |
| Week 3 | $13.81 | $17.47 | $22.09 | +0.63% |
| Week 4 | $13.35 | $17.51 | $22.96 | +0.84% |
| Week 5 | $12.96 | $17.54 | $23.75 | +1.05% |
| Week 6 | $12.61 | $17.58 | $24.50 | +1.26% |
| Week 7 | $12.31 | $17.62 | $25.21 | +1.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Summit Therapeutics Inc. is a biopharmaceutical company that focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC).
The company markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
SMMT trades at $16.62 per share with a market cap of $12.9B and a rank of 772 by market capitalization. The current price sits below the nearby moving averages, with SMA50 at $18.89 and SMA200 at $18.97, signaling near-term upside potential if prices rally above these levels. The 30-day price range runs from $11.63 to $23.76, and overall sentiment is NEUTRAL for the period.
A major floor 46.2% below — a decisive break under it would weaken the trend.
The nearest floor, 8.7% below — buyers have tended to step in here.
The nearest ceiling, 52.0% above — a clean break opens room to run.
A major ceiling 75.1% above — clearing it would confirm fresh momentum.
Key SMMT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SMMT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.27 | Buy | $17.14 | Buy |
| MA 10 | $17.20 | Buy | $17.34 | Buy |
| MA 20 | $17.78 | Sell | $17.98 | Sell |
| MA 50 | $18.93 | Sell | $18.38 | Sell |
| MA 100 | $17.51 | Sell | $18.30 | Sell |
| MA 200 | $18.85 | Sell | $18.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.71 | Neutral |
| Stoch RSI (14) | 81.04 | Sell |
| CCI (20) | -26.45 | Neutral |
| Williams %R (14) | -51.29 | Info |
| MACD (12,26,9) | -0.07 | Sell |
| ROC (12) | -3.98 | Sell |
| Bollinger %B (20,2) | 0.43 | Neutral |
| Stochastic %K (14) | 48.71 | Neutral |
| TRIX (15) | -0.54 | Sell |
| Awesome (5,34) | -2.44 | Sell |
| Ultimate (7,14,28) | 50.02 | Neutral |
| Momentum (10) | -1.59 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 17.16 | Buy |
| ADX (14) | 17.21 | Neutral |
| ATR (14) | 0.79 | Info |
The RSI(14) is 40, indicating neutral momentum in the current window. Price is trading below both the 50-day and 200-day simple moving averages (SMA50 = $18.89, SMA200 = $18.97), which can act as near-term resistance if not cleared. Support is at $15.85 and resistance at $26.38, framing the immediate trading range and potential turning points.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.85 | $17.36 | $26.06 | 0% | Neutral | |
| $17.35 | $23.90 | $35.61 | +38% | Bullish | |
| $16.36 | $23.85 | $37.70 | +37% | Bullish | |
| $16.86 | $25.81 | $42.73 | +49% | Bullish | |
| $16.65 | $26.64 | $45.81 | +53% | Bullish | |
| $17.25 | $28.77 | $51.13 | +66% | Bullish | |
| $26.17 | $45.38 | $83.08 | +161% | Bullish | |
| $27.19 | $48.97 | $92.05 | +182% | Bullish | |
| $23.85 | $44.57 | $85.82 | +157% | Bullish | |
| $26.59 | $51.53 | $101.45 | +197% | Bullish | |
| $38.16 | $84.80 | $182.96 | +388% | Bullish | |
| $75.26 | $167.25 | $384.68 | +863% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.85 | $17.36 | $20.78 | +0.00% |
| June 2026 | $14.97 | $17.92 | $22.21 | +3.23% |
| July 2026 | $14.66 | $17.84 | $22.65 | -0.46% |
| August 2026 | $15.25 | $18.79 | $24.30 | +5.31% |
| September 2026 | $15.56 | $19.37 | $25.44 | +3.12% |
| October 2026 | $14.75 | $18.55 | $24.69 | -4.24% |
| November 2026 | $14.39 | $18.25 | $24.58 | -1.63% |
| December 2026 | $14.96 | $19.14 | $26.06 | +4.87% |
Click any year to see its month-by-month SMMT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Summit Therapeutics Inc.'s 2026 outlook centres on $17.36, within a $13.85 to $26.06 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SMMT could reach as high as $35.61, with a base case around $23.90 and support toward $17.35 — roughly +38% from $17.36. Buyers look set to stay in control over this stretch.
Expect SMMT to range from $16.36 to $37.70 through 2028. The $23.85 average target implies a +37% move from current prices. That is 0% versus the projected 2027 average. Momentum favours further upside here.
The SMMT price prediction for 2029 points to an average of $25.81 (low $16.86, high $42.73) — a potential gain of +49% on today's $17.36. Buyers look set to stay in control over this stretch.
In 2030, SMMT is projected to trade between $16.65 and $45.81, averaging $26.64 — a potential gain of +53% from today's $17.36. That is up +3% on the projected 2029 average. Momentum favours further upside here.
Summit Therapeutics Inc.'s 2031 outlook centres on $28.77, within a $17.25 to $51.13 range. That is up +8% on the projected 2030 average. That marks a +66% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SMMT could reach as high as $83.08, with a base case around $45.38 and support toward $26.17 — roughly +161% from $17.36. Momentum favours further upside here.
Expect SMMT to range from $27.19 to $92.05 through 2033. The $48.97 average target implies a +182% move from current prices. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SMMT price prediction for 2034 points to an average of $44.57 (low $23.85, high $85.82) — a potential gain of +157% on today's $17.36. Momentum favours further upside here.
In 2035, SMMT is projected to trade between $26.59 and $101.45, averaging $51.53 — a potential gain of +197% from today's $17.36. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Summit Therapeutics Inc.'s 2040 outlook centres on $84.80, within a $38.16 to $182.96 range. That is up +65% on the projected 2035 average. That marks a +388% change versus current levels. Momentum favours further upside here.
By 2050, SMMT could reach as high as $384.68, with a base case around $167.25 and support toward $75.26 — roughly +863% from $17.36. Buyers look set to stay in control over this stretch.
Investing $1,000 in SMMT today (≈ 57.603687 SMMT) could be worth
$9,634.27
+$8,634.27 (+863%) by 2050 · US Dollar
Based on the average projected SMMT price of $167.25 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SMMTwould be worth at today's price.
$1,000 invested in SMMT on May 27, 2025 (≈ 39.001561 SMMT) would be worth
$677.07
-$322.93 (-32.3%) today · 0.68× · US Dollar
Based on a SMMT entry price of $25.64 vs. today's $17.36.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.89 | $970.37 | -3.0% |
| 1 month ago | $22.12 | $784.81 | -21.5% |
| 3 months ago | $15.8 | $1,098.73 | +9.9% |
| 6 months ago | $17.89 | $970.37 | -3.0% |
| 1 year ago | $25.64 | $677.07 | -32.3% |
| All time (5.0y) ago | $7.95 | $2,183.65 | +118.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SMMT forecast.
Our base-case forecast reaches $35.00 around 2032.
Implied market cap at $35.00: $27.17B
Forecasts extend well into the next several years with a bullish tilt starting from 2027. The 2026 forecast shows a min of $13.85, an average of $16.62, a max of $25.30, and 0% ROI with NEUTRAL sentiment. In 2027 the average rises to $22.80 (ROI 37.2%, BULLISH), and 2028 shows $22.83 (ROI 37.4%, BULLISH).
The 2029 forecast is $24.33 (ROI 46.4%), and 2030 reaches $24.60 (ROI 48%, BULLISH). By 2031 the average is $27.01 (ROI 62.5%, BULLISH). The path continues with 2032 at $43.05 (ROI 159.1%), 2033 at $45.72 (ROI 175.1%), 2034 at $41.61 (ROI 150.4%), and 2035 at $48.36 (ROI 190.9%).
Longer horizons project continued upside: 2040 average $79.15 (ROI 376.3%, BULLISH) and 2050 average $154.29 (ROI 828.3%, BULLISH). These figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast has an average price of $24.60 with a min of $15.11 and a max of $42.91, and an expected ROI of 48% (sentiment BULLISH).
Forecasts show a bullish sentiment from 2027 onward with rising averages (e.g., 2027 avg $22.80; 2030 avg $24.60; 2050 avg $154.29) and ROI up to 828.3%. These are estimates and not guarantees.
Yes. The forecast max reaches $174.14 in 2040 and $354.87 in 2050, indicating potential to exceed $100 according to the projections.
Current price is $16.62 and market cap is $12.9B.
The 30-day range is from $11.63 up to $23.76.
Summit Therapeutics Inc. Community Discussion
0Share your Summit Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.